ERBB2 and neoplasm: Recent studies have shown that miR-489 expression is down-regulated in various tumor tissues, and this inhibits the expression of its target genes, such as HER2, AKT3, and SPIN1. Thus, miR-489 participates in various pathologies such as the proliferation, apoptosis, invasion, and metastasis of tumor cells (Sun et al., 2017).